Month: May 2013

Toronto, ON, Canada – The National Institute for Health and Care Excellence (NICE) is highly regarded for the rigorous methods it adopts for the economic appraisal of health care technologies. A recent amendment to these appraisal methods, however, raises a number…

Bolton, MA, USA – The use of secondary data sources is growing in oncology health services research. Identifying patients with cancer from these data can be difficult due to the lack of clinical detail in secondary data. As a result, researchers…

Leicester, UK – It is essential that the relationships between diagnostic tests are understood in order to ensure the most effective diagnoses of diseases, as they rarely perform independently. To date, both clinical and economic evaluations of combinations of diagnostic tests…

State College, PA, USA – Increasingly, information about the benefits of a treatment is being obtained directly from patients, clinicians, and patients’ observers using clinical outcomes assessments (COAs). Clinical outcomes assessments are used to inform individual medical decisions as well as…

High Wycombe, UK – Improvements in ovarian cancer survival rates have been modest with a median survival after recurrence of just two years. Patients with disease relapsing more than six months after completion of a platinum chemotherapy regimen are said to…

Boston, MA, USA – Researchers from the Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts Medical Center have illustrated potential health gains from using cost-effectiveness evidence to inform Medicare resource allocation for medical technology. Focusing on interventions…

Kyoto, Japan –The number of cases of hyperlipidemia in Japan has been increasing, with an estimated 1.43 million patients diagnosed with hyperlipidemia in 2006. Despite the high prevalence of hyperlipidemia in Japan, the incidence of coronary artery disease (CAD) is…